The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ATYR PHARMA INC | COM NEW | 002120202 | 1,289 | 332,258 | SH | SOLE | 332,258 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 2,107 | 267,753 | SH | SOLE | 267,753 | 0 | 0 | ||
ALPHA HEALTHCARE ACQUISTN CO | UNIT 09/21/2027 | 020751202 | 2,907 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
AMPLITUDE HLTHCRE AQUSTIN CO | *W EXP 12/01/202 | 03212A113 | 236 | 162,500 | SH | SOLE | 162,500 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 5,616 | 261,209 | SH | SOLE | 261,209 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 1,771 | 62,962 | SH | SOLE | 62,962 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 4,065 | 293,917 | SH | SOLE | 293,917 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 3,110 | 465,589 | SH | SOLE | 465,589 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 1,373 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 5,149 | 1,682,535 | SH | SOLE | 1,682,535 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 1,863 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 1,897 | 588,992 | SH | SOLE | 588,992 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 3,338 | 185,552 | SH | SOLE | 185,552 | 0 | 0 | ||
CASTLE BIOSCIENCES INC | COM | 14843C105 | 4,163 | 61,991 | SH | SOLE | 61,991 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 1,980 | 313,745 | SH | SOLE | 313,745 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 4,196 | 239,520 | SH | SOLE | 239,520 | 0 | 0 | ||
CELLECTAR BIOSCIENCES INC | COM PAR | 15117F500 | 1,772 | 851,852 | SH | SOLE | 851,852 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | *W EXP 06/09/202 | 15678U102 | 365 | 64,666 | SH | SOLE | 64,666 | 0 | 0 | ||
CHARDAN HEALTHCR ACQSTN 2 CO | COM | 15957T107 | 3,966 | 388,845 | SH | SOLE | 388,845 | 0 | 0 | ||
CHARDAN HEALTHCR ACQSTN 2 CO | *W EXP 03/05/202 | 15957T115 | 495 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 3,264 | 205,799 | SH | SOLE | 205,799 | 0 | 0 | ||
CNS PHARMACEUTICALS INC | COM | 18978H102 | 951 | 534,148 | SH | SOLE | 534,148 | 0 | 0 | ||
CM LIFE SCIENCES INC | UNIT 09/01/2025 | 18978W208 | 2,320 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 4,858 | 432,563 | SH | SOLE | 432,563 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 3,770 | 216,925 | SH | SOLE | 216,925 | 0 | 0 | ||
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 3,866 | 134,233 | SH | SOLE | 134,233 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 5,107 | 361,930 | SH | SOLE | 361,930 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 6,732 | 822,009 | SH | SOLE | 822,009 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 1,793 | 273,703 | SH | SOLE | 273,703 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 2,033 | 5,500 | SH | SOLE | 5,500 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 2,427 | 197,500 | SH | SOLE | 197,500 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 1,412 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 2,089 | 175,067 | SH | SOLE | 175,067 | 0 | 0 | ||
FAT BRANDS INC | *W EXP 06/30/202 | 30258N121 | 810 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
FS DEV CORP | COM CL A | 303020101 | 2,574 | 234,000 | SH | SOLE | 234,000 | 0 | 0 | ||
GENPREX INC | COM | 372446104 | 5,851 | 1,409,785 | SH | SOLE | 1,409,785 | 0 | 0 | ||
GLOBUS MED INC | CL A | 379577208 | 2,055 | 31,512 | SH | SOLE | 31,512 | 0 | 0 | ||
HAEMONETICS CORP | COM | 405024100 | 3,105 | 26,144 | SH | SOLE | 26,144 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 1,694 | 101,994 | SH | SOLE | 101,994 | 0 | 0 | ||
ICU MED INC | COM | 44930G107 | 1,999 | 9,321 | SH | SOLE | 9,321 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 4,144 | 11,200 | SH | SOLE | 11,200 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 3,585 | 77,622 | SH | SOLE | 77,622 | 0 | 0 | ||
IMMUNIC INC | COM | 4525EP101 | 3,733 | 244,155 | SH | SOLE | 244,155 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 4,952 | 148,743 | SH | SOLE | 148,743 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 4,141 | 16,200 | SH | SOLE | 16,200 | 0 | 0 | ||
INTERSECT ENT INC | COM | 46071F103 | 2,282 | 99,661 | SH | SOLE | 99,661 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 4,876 | 153,348 | SH | SOLE | 153,348 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 6,237 | 902,633 | SH | SOLE | 902,633 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,060 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 2,074 | 133,951 | SH | SOLE | 133,951 | 0 | 0 | ||
KUBIENT INC | COM | 50116V107 | 236 | 42,269 | SH | SOLE | 42,269 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 3,541 | 262,465 | SH | SOLE | 262,465 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 1,997 | 93,261 | SH | SOLE | 93,261 | 0 | 0 | ||
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 2,668 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
LYRA THERAPEUTICS INC | COM | 55234L105 | 59 | 5,218 | SH | SOLE | 5,218 | 0 | 0 | ||
MICT INC | COM | 55328R109 | 3,190 | 1,533,425 | SH | SOLE | 1,533,425 | 0 | 0 | ||
MYRIAD GENETICS INC | COM | 62855J104 | 4,324 | 218,650 | SH | SOLE | 218,650 | 0 | 0 | ||
NANO DIMENSION LTD | SPONSORD ADS NEW | 63008G203 | 2,772 | 304,600 | SH | SOLE | 304,600 | 0 | 0 | ||
9 METERS BIOPHARMA INC | COM | 654405109 | 1,087 | 1,264,994 | SH | SOLE | 1,264,994 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 6,276 | 303,174 | SH | SOLE | 303,174 | 0 | 0 | ||
OCUPHIRE PHARMA INC | COM | 67577R102 | 5,812 | 895,481 | SH | SOLE | 895,481 | 0 | 0 | ||
OCUPHIRE PHARMA INC | COM | 67577R102 | 7,613 | 1,173,049 | SH | SOLE | 1,173,049 | 0 | 0 | ||
ONCTERNAL THERAPEUTICS INC | COM | 68236P107 | 2,017 | 411,667 | SH | SOLE | 411,667 | 0 | 0 | ||
OPENDOOR TECHNOLOGIES INC | *W EXP 12/18/202 | 683712111 | 1,853 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 1,899 | 458,589 | SH | SOLE | 458,589 | 0 | 0 | ||
ORBITAL ENERGY GROUP INC | COM | 68559A109 | 2,965 | 1,353,995 | SH | SOLE | 1,353,995 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 1,940 | 299,890 | SH | SOLE | 299,890 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 3,747 | 185,854 | SH | SOLE | 185,854 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 1,999 | 571,026 | SH | SOLE | 571,026 | 0 | 0 | ||
ROTH CH ACQUISITION II CO | UNIT 12/11/2025 | 778673202 | 1,040 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 3,060 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
SIENTRA INC | COM | 82621J105 | 2,928 | 752,634 | SH | SOLE | 752,634 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 6,008 | 276,719 | SH | SOLE | 276,719 | 0 | 0 | ||
SWITCHBACK ENERGY ACQUISTN C | *W EXP 07/25/202 | 87105M110 | 1,619 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 5,862 | 263,596 | SH | SOLE | 263,596 | 0 | 0 | ||
TCR2 THERAPEUTICS INC | COM | 87808K106 | 2,289 | 73,991 | SH | SOLE | 73,991 | 0 | 0 | ||
TIZIANA LIFE SCIENCES PLC | SPONSORED ADS | 88875G101 | 2,177 | 1,077,883 | SH | SOLE | 1,077,883 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 2,085 | 76,484 | SH | SOLE | 76,484 | 0 | 0 | ||
VENUS CONCEPT INC | COM | 92332W105 | 162 | 93,643 | SH | SOLE | 93,643 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 5,819 | 2,731,974 | SH | SOLE | 2,731,974 | 0 | 0 | ||
VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 1,252 | 108,794 | SH | SOLE | 108,794 | 0 | 0 | ||
VINCERA PHARMA INC | COM | 92731L106 | 3,140 | 150,150 | SH | SOLE | 150,150 | 0 | 0 | ||
VINCERA PHARMA INC | *W EXP 12/24/202 | 92731L114 | 710 | 215,250 | SH | SOLE | 215,250 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 1,114 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CONSONANCE HFW ACQUISITION C | UNIT 99/99/9999 | G2445M129 | 2,618 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 4,264 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ARYA SCIENCES ACQUISITION CO | COM CL A | G3166W106 | 4,340 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
GALILEO ACQUISITION CORP | *W EXP 10/31/202 | G3770A110 | 168 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 128 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 2,843 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
QUOTIENT LTD | SHS | G73268107 | 130 | 24,912 | SH | SOLE | 24,912 | 0 | 0 | ||
SARISSA CAPITAL ACQUISITN CO | UNIT 10/23/2027 | G7823W128 | 2,396 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | UNIT 10/08/2025 | G9127T116 | 2,609 | 254,000 | SH | SOLE | 254,000 | 0 | 0 | ||
IMMATICS N.V. | SHS | N44445109 | 4,377 | 405,670 | SH | SOLE | 405,670 | 0 | 0 | ||
IMMATICS N.V. | *W EXP 07/01/202 | N44445117 | 281 | 97,467 | SH | SOLE | 97,467 | 0 | 0 |